Home Newsfeeds Citigroup Maintains Buy on Datadog, Lowers Price Target to $100

Citigroup Maintains Buy on Datadog, Lowers Price Target to $100

Citigroup analyst Fatima Boolani maintains Datadog (NASDAQ:DDOG) with a Buy and lowers the price target from $170 to $100.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Citigroup analyst Fatima Boolani maintains Datadog (NASDAQ:DDOG) with a Buy and lowers the price target from $170 to $100.

Inventiva Announces The Positive Recommendation Of The Third DMC Of The Phase III Clinical Trial With Lanifibranor In Patients With NASH

By Benzinga Newsdesk

December 4, 5:17 PM

The DMC recommended to continue the clinical trial without modification of the protocol, based on the pre-planned review of safety dataThe safety assessment was based on the review of safety data from more than 500

IVA

What’s Going On With Taiwan Semiconductor Manufacturing Stock Friday?

By Anusuya Lahiri

February 16, 11:15 AM

TSMC's stock value increased by $42 billion thanks to AI frenzy, making it world's 12th most valuable company, surpassing Visa. Morgan Stanley raised its price target by 9% due to demand for advanced chips and Nvidia's impact. TSMC plans to increase capital spending and is at the forefront of chip technology.

NVDA

Lifecore Biomedical Enters Into $150M In New Financing, Repays its Outstanding Term Loans And Signs New Supply Agreement To Expand HA Fermentation Capacity With Existing Long-Term Customer, Alcon

By Benzinga Newsdesk

May 22, 5:03 PM

Lifecore Biomedical, Inc. (NASDAQ:LFCR), a fully integrated contract development and manufacturing organization ("CDMO"), today announced that it has entered into a broad set of agreements with its long-term customer,

ALC

Analysts Launch Coverage On Marex Group Stock: What You Need To Know

By Vaishali Prayag

May 20, 2:50 PM

Marex Group shares are starting to gain positive momentum following the company's IPO last month. Several analyst firms initiated coverage on the stock on Monday.

MRX

Citigroup Maintains Buy on Datadog, Lowers Price Target to $100

Related Posts

Inventiva Announces The Positive Recommendation Of The Third DMC Of The Phase III Clinical Trial With Lanifibranor In Patients With NASH

What’s Going On With Taiwan Semiconductor Manufacturing Stock Friday?

Lifecore Biomedical Enters Into $150M In New Financing, Repays its Outstanding Term Loans And Signs New Supply Agreement To Expand HA Fermentation Capacity With Existing Long-Term Customer, Alcon

Analysts Launch Coverage On Marex Group Stock: What You Need To Know